Azienda Ospedaliera "Carlo Poma", Mantova
Data on the efficacy and tolerability of dasatinib in the treatment of chronic myeloid leukaemia (CML) derive from studies on extremely selected groups of patients, and so information from very elderly patients and patients with severe comorbid conditions are very scarce. This can lead to suboptima...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
PAGEPress Publications
2014-08-01
|
Series: | Mediterranean Journal of Hematology and Infectious Diseases |
Subjects: | |
Online Access: | https://mjhid.org/index.php/mjhid/article/view/1853 |